These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34182907)

  • 1. A Review on Pharmacokinetic and Pharmacodynamic Drug Interactions of Adrenergic β-blockers with Clinically Relevant Drugs-An Overview.
    Maideen NMP; Rajkapoor B; Muthusamy S; Ramanathan S; Thangadurai SA; Sughir AA
    Curr Drug Metab; 2021; 22(9):672-682. PubMed ID: 34182907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-drug interactions of beta-adrenoceptor blockers.
    Brodde OE; Kroemer HK
    Arzneimittelforschung; 2003; 53(12):814-22. PubMed ID: 14732961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta blockers in migraine prophylaxis].
    Shimizu T
    Brain Nerve; 2009 Oct; 61(10):1125-30. PubMed ID: 19882938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Antidepressants with β-Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction.
    Shin J; Hills NK; Finley PR
    Pharmacotherapy; 2020 Jun; 40(6):507-516. PubMed ID: 32342526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
    Esler M; Kjeldsen SE; Pathak A; Grassi G; Kreutz R; Mancia G
    Blood Press; 2022 Dec; 31(1):210-224. PubMed ID: 36029011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-blockers. Drug interactions of clinical significance.
    Blaufarb I; Pfeifer TM; Frishman WH
    Drug Saf; 1995 Dec; 13(6):359-70. PubMed ID: 8652080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R; Brocks DR
    J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments.
    Sternieri E; Coccia CP; Pinetti D; Guerzoni S; Ferrari A
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):981-1007. PubMed ID: 17125412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects.
    Damy T; Pousset F; Caplain H; Hulot JS; Lechat P
    Fundam Clin Pharmacol; 2004 Feb; 18(1):113-23. PubMed ID: 14748763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
    Mutschler E; Spahn H; Kirch W
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):51S-57S. PubMed ID: 6146340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentially significant drug interactions of class III antiarrhythmic drugs.
    Yamreudeewong W; DeBisschop M; Martin LG; Lower DL
    Drug Saf; 2003; 26(6):421-38. PubMed ID: 12688833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A toxicological review of beta-adrenergic blockers.
    Jackson CD; Fishbein L
    Fundam Appl Toxicol; 1986 Apr; 6(3):395-422. PubMed ID: 2870945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
    Bauman JL; Talbert RL
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity.
    Hamelin BA; Bouayad A; Méthot J; Jobin J; Desgagnés P; Poirier P; Allaire J; Dumesnil J; Turgeon J
    Clin Pharmacol Ther; 2000 May; 67(5):466-77. PubMed ID: 10824625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
    Cheymol G; Poirier JM; Carrupt PA; Testa B; Weissenburger J; Levron JC; Snoeck E
    Br J Clin Pharmacol; 1997 Jun; 43(6):563-70. PubMed ID: 9205815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta blockers and lactation: an update.
    Shannon ME; Malecha SE; Cha AJ
    J Hum Lact; 2000 Aug; 16(3):240-5. PubMed ID: 11153162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular drug class specificity: beta-blockers.
    Reiter MJ
    Prog Cardiovasc Dis; 2004; 47(1):11-33. PubMed ID: 15517513
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.